Unique ID issued by UMIN | UMIN000038827 |
---|---|
Receipt number | R000043795 |
Scientific Title | Bavencio Intravenous 200 mg Special Drug Use - results Survey (Curatively unresectable Merkel cell carcinoma) |
Date of disclosure of the study information | 2019/12/10 |
Last modified on | 2024/02/19 10:10:51 |
Bavencio Intravenous 200 mg Special Drug Use - results Survey (Curatively unresectable Merkel cell carcinoma)
Bavencio Special Drug Use-results Survey (Merkel cell carcinoma)
Bavencio Intravenous 200 mg Special Drug Use - results Survey (Curatively unresectable Merkel cell carcinoma)
Bavencio Special Drug Use-results Survey (Merkel cell carcinoma)
Japan |
Curatively unresectable Merkel cell carcinoma
Hematology and clinical oncology | Dermatology |
Malignancy
NO
Survey of safety and efficacy of Bavencio Intravenous 200 mg in clinical practice
Safety,Efficacy
The safety parameters (occurrence of adverse drug reactions and serious adverse events, etc.)
Efficacy (response rate)
Observational
Not applicable |
Not applicable |
Male and Female
All patients who received at least one dose of this drug during the enrollment period from November 22, 2017 to November 2, 2022.
None
48
1st name | Hidehiko |
Middle name | |
Last name | Momo |
Merck Biopharma Co., Ltd.
PMS Planning & Strategy, Medical Department
153-8926
Arco Tower 4F, 8-1, Shimomeguro 1-chome, Meguro-ku, Tokyo, Japan
03-6756-0791
hidehiko.momo@merckgroup.com
1st name | Taito |
Middle name | |
Last name | Ito |
Merck Biopharma Co., Ltd.
PMS Planning & Strategy, Medical Department
153-8926
Arco Tower 4F, 8-1, Shimomeguro 1-chome, Meguro-ku, Tokyo, Japan
03-6756-0805
taito.ito@merckgroup.com
Merck Biopharma Co., Ltd.
Merck Biopharma Co., Ltd.
Profit organization
Merck Biopharma Co., Ltd.
Arco Tower 4F, 8-1, Shimomeguro 1-chome, Meguro-ku, Tokyo, Japan
03-6756-0805
taito.ito@merckgroup.com
NO
2019 | Year | 12 | Month | 10 | Day |
Unpublished
78
Completed
2017 | Year | 11 | Month | 06 | Day |
2017 | Year | 11 | Month | 06 | Day |
2017 | Year | 11 | Month | 22 | Day |
2022 | Year | 11 | Month | 02 | Day |
Special Drug Use-Results Survey according to the GPSP ordinance
2019 | Year | 12 | Month | 09 | Day |
2024 | Year | 02 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043795
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |